Genmab
GMAB
GMAB
226 hedge funds and large institutions have $1.44B invested in Genmab in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 88 increasing their positions, 73 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $1.51B → $1.44B (-$77.7M)
28% less call options, than puts
Call options by funds: $977K | Put options by funds: $1.36M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
226
Holding in Top 10
–
Calls
$977K
Puts
$1.36M
Top Buyers
| 1 | +$22M | |
| 2 | +$19.7M | |
| 3 | +$9.43M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$8.11M |
| 5 |
Two Sigma Investments
New York
|
+$7.5M |
Top Sellers
| 1 | -$36M | |
| 2 | -$13.2M | |
| 3 | -$10.8M | |
| 4 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
-$6.59M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.03M |